MET and nonpapillary renal cell carcinoma: Importantly, the gene set (SAA1, SAA2, APOL1, and MET) that characterizes metastatic ccRCC from previous studies exhibited significant expression in the MT + group (Alchahin et al., 2022) (Figure 3T).